European Bioanalysis Forum
5th Open Symposium
Old Battles - New Horizons
November 14-16, 2012 •
Hesperia Tower Hotel • Barcelona • Spain
LAST CALL FOR SPEAKERS/POSTERS
Only 3 weeks until
the submission deadline for oral presentations and competing posters!
The theme of the 5th Open Symposium is "Old Battles – New Horizons", where
we intend to discuss ongoing ambiguities in areas like the tiered approach,
micro sampling and tissue analysis as well as new and cutting edge applications
in LBA and LC-MS/MS. We anticipate to
bring an exciting program which combines above with regulated bioanalysis
themes, including updates from the globe (i.e. GBC and emerging
regulations). The draft program can be
found on our website at: http://bcn2012.europeanbioanalysisforum.eu/Program/
LASTEST
PROGRAM UPDATE:
Following up on the recent announcements on an upcoming Crystal City
(CC-V) meeting on the (to be released) draft FDA BMV guidance (http://www.aaps.org/BMV), the
Organizing Committee (OSOC) has decided to adapt the program of the Open
Symposium and host a 1-day discussion on Friday Nov. 16th on the draft
Guideline in front of this planned CC-V meeting (in continuation of this mail
called ‘EBF FDA-BMV guidelines session’). We anticipate to create minimal
impact on the original content of our 5th Symposium. The sessions that were
originally scheduled for Friday will be included in the program of Nov. 14th
and 15th, either by shortening some other sessions or by creating additional
breakouts. The OSOC will work out a detailed agenda in the coming weeks.
In the EBF FDA-BMV guidelines session, it is our goal to include
speakers who are closely involved in the preparation of the CC-V meeting,
provide feedback from speakers around the globe and discuss the EBF
consolidated feedback. Breakouts will be arranged for small
molecules/chromatography and large molecules/LBA discussions.
We are aware of the current vagueness of the AAPS announcement. Of
course, if no draft FDA Guideline is available at the time of the EBF Open
Symposium, we will re-adapt the program accordingly, with focus of the Friday
remaining on emerging guidelines as originally planned.
ORAL PRESENTATIONS
Speakers are requested to submit
their contribution to open@europeanbioanalysisforum.eu, before September 10th 2012, providing title of the presentation, a recent bio (max 150
words) and an abstract (max 350 words). The registration fee is waived for
accepted speakers. As the summer breaks are approaching rapidly, do not
hesitate to submit your talk soon. And preferably identify the session you plan
to contribute to. See also: http://bcn2012.europeanbioanalysisforum.eu/Speakers/.
POSTERS
The EBF would also like to invite
registrations for posters. This year, there will be a different approach to the
poster sessions. You can either submit a regular poster (before October
15th 2012)
or apply for the ‘Best Poster‘ content (in which case you poster + abstract
needs to be submitted before
September 10th2012
(see more details on the poster
registration form at: http://bcn2012.europeanbioanalysisforum.eu/Posters/). All posters, need to be submitted to: open@europeanbioanalysisforum.eu
--------------------------------------------------------------------------------------------------------------------------------------------------
Meeting Organisation
Richard
Abbott (Shire), Begona Barroso (Astellas), Magnus Knutsson (Ferring), Steve
White (GSK), Peter van Amsterdam (Abbott), Margarete Brudny-Kloeppel (Bayer
Healthcare), Arjen Companjen (Crucell), Michaela Golob (Merck-Serono), Silke
Luedtke (Boehringer Ingelheim), Philip Timmerman (Janssen R&D),
Sponsor relations, marketing and
logistics: Christina Smith, Bavalan
Bioconference SARL
The
conference is organised as a non-profit event on behalf of the EBF vzw
The organisation of the conference is independent of all EBF member companies and conference sponsors.
The organisation of the conference is independent of all EBF member companies and conference sponsors.
Posts
